NIH-funded research R01 grant

Identifying and validating new genetic variants linked to congenital diaphragmatic hernia

Official title: Functional Validation of Novel Variants Associated with Congenital Diaphragmatic Hernia

Funded at Jackson Laboratory · NIH-10942353 · Data updated 2026-11-12

This study is looking at congenital diaphragmatic hernia (CDH), a birth defect that can cause breathing problems in babies, and it aims to find new genetic clues that could help us understand and treat this condition better, using special technology to test these clues in mice.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJackson Laboratory
NIH-funded
Lab location1 site (Bar Harbor, United States)
Project startSeptember 7, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$757,089
NIH project number1R01HD115718-01
Project IDNIH-10942353 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants diagnosed with congenital diaphragmatic hernia or those with a family history of the condition.

Less likely to help

Patients with congenital diaphragmatic hernia who do not have a genetic component or those outside the age range of 0-11 years may not benefit from this research.

What this research studies

This research focuses on congenital diaphragmatic hernia (CDH), a serious birth defect affecting the diaphragm, leading to severe respiratory issues in infants. The team aims to discover and validate new genetic variants associated with CDH using advanced CRISPR/Cas9 technology, which allows for rapid testing in mouse models. By identifying these genetic factors, the research seeks to enhance our understanding of CDH and improve potential treatment options for affected infants. The study will leverage genome data from a large cohort to ensure comprehensive analysis.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and targeted therapies for infants born with congenital diaphragmatic hernia.

How similar studies have gone: Previous research using CRISPR technology for genetic validation in other congenital conditions has shown promising results, indicating a potential for success in this novel approach.

Where this research is happening

  • Jackson Laboratory
    Bar Harbor, United States
    Active

Researchers

  • Principal investigator: Murray, Stephen a — Jackson Laboratory
  • Study coordinator: Murray, Stephen a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.